Literatur
- 1
MacLusky I B, Gold R, Corey M et al.
Long-term effects of inhaled tobramycin in patients with cystic fibrosis colonized
with Pseudomonas aeruginosa.
Pediatr Pulmonol.
1989;
7
42-48
- 2
Wiesemann H G, Steinkamp G, Ratjen F et al.
Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early
treatment of Pseudomonas aeruginosa colonization in cystic fibrosis.
Pediatr Pulmonol.
1998;
25
88-92
- 3
Ramsey B W, Pepe M S, Quan J M et al.
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis.
Cystic Fibrosis Inhaled Tobramycin Study Group.
N Engl J Med.
1999;
340
23-30
- 4
Moss R B.
Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis.
Chest.
2002;
121
55-63
- 5
Hodson M E, Gallagher C G, Govan J R.
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis.
Eur Respir J.
2002;
20
658-664
- 6
Gibson R L, Emerson J, McNamara S et al.
Significant microbiological effect of inhaled tobramycin in young children with cystic
fibrosis.
Am J Respir Crit Care Med.
2003;
167
841-849
- 7
Angrill J, Agustí C, de Celis R et al.
Bacterial colonisation in patients with bronchiectasis: microbiological pattern and
risk factors.
Thorax.
2002;
57
15-19
- 8
Drobnic M E, Suñé P, Montoro J B et al.
Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic
bronchial infection with Pseudomonas aeruginosa.
Ann Pharmacother.
2005;
39
39-44
- 9
Hallal A, Cohn S M, Namias N et al.
Aerosolized tobramycin in the treatment of ventilator-associated pneumonia: a pilot
study.
Surg Infect.
2007;
8
73-82
- 10
Gales A C, Reis A O, Jones R N.
Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin
B and colistin: review of available interpretative criteria and quality control guidelines.
Clin Microbiol.
2001;
39
83-190
- 11
Hogardt M, Schmoldt S, Götzfried M et al.
Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa
isolated from cystic fibrosis patients.
J Antimicrob Chemother.
2004;
54
1057-1061
- 12
Herrmann G, Yang L, Wu H et al.
Colistin-tobramycin combinations are superior to monotherapy concerning the killing
of biofilm Pseudomonas aeruginosa.
J Infect Dis.
2010;
202
585-1592
- 13
Valerius N H, Koch C, Høhiby N.
Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early
treatment.
Lancet.
1991;
338
725-726
- 14
Jensen T, Pedersen S S, Garne S et al.
Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa
lung infection.
J Antimicrob Chemother.
1987;
19
831-838
- 15
Høiby N, Frederiksen B, Pressler T.
Eradication of early Pseudomonas aeruginosa infection.
J Cyst Fibros.
2005;
4
49-54
- 16
Rademacher J, Pletz M W, Welte T.
Treatment of not-with cystic fibrosis associated forms bronchiectasis (non-CF bronchiectasis).
Internist.
2010;
51
1510-1515
- 17
Steinfort D P, Steinfort C.
Effect of long-term nebulized colistin on lung function and quality of life in patients
with chronic bronchial sepsis.
Intern Med J.
2007;
37
495-498
- 18
Dhar R, Anwar G A, Bourke S C et al.
Efficacy of nebulised colomycin in patients with non-cystic fibrosis bronchiectasis
colonised with Pseudomonas aeruginosa.
Thorax.
2010;
65
553
- 19
Michalopoulos A, Kasiakou S K, Falagas M E.
The significance of different formulations of aerosolized colistin.
Crit Care.
2005;
9
417-418
- 20
Kwa A L, Loh C, Low J G et al.
Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter
baumannii and Pseudomonas aeruginosa.
Clin Infect Dis.
2005;
41
754-757
- 21
Berlana D, Llop J M, Fort E, Badia M B, Jódar R.
Use of colistin in the treatment of multiple-drug-resistant gram-negative infections.
Am J Health Syst Pharm.
2005;
62
39-47
- 22
Michalopoulos A, Fotakis D, Virtzili S et al.
Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due
to multidrug-resistant Gram-negative bacteria: a prospective study.
Respir Med.
2008;
102
407-412
- 23
McCoy K S, Quittner A L, Oermann C M et al.
Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.
Am J Respir Crit Care Med.
2008;
178
21-928
- 24
Oermann C M, Retsch-Bogart G Z, Quittner A L et al.
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam
lysine in cystic fibrosis.
Pediatr Pulmonol.
2010;
45
1121-1134
- 25
Heinzl B, Eber E, Oberwaldner B et al.
Effects of inhaled gentamicin prophylaxis on acquisition of Pseudomonas aeruginosa
in children with cystic fibrosis: a pilot study.
Pediatr Pulmonol.
2002;
33
32-7
- 26
Murray M P, Govan J R, Doherty C J et al.
A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis.
Am J Respir Crit Care Med.
2011;
183
491-499
- 27
Palmer L B, Smaldone G C, Simon S R et al.
Aerosolized antibiotics in mechanically ventilated patients: delivery and response.
Crit Care Med.
1998;
26
31-39
- 28
Ghannam D E, Rodriguez G H, Raad I I et al.
Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative
bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.
Eur J Clin Microbiol Infect Dis.
2009;
28
253-259
- 29
Morgan J, Wannemuehler K A, Marr K A et al.
Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ
transplantation: interim results of a prospective multicenter surveillance program.
Med Mycol.
2005;
43
49-58
- 30
Drew R H.
Aerosol and other novel administrations for prevention and treatment of invasive aspergillosis.
Med Mycol.
2009;
47
355-361
- 31
Knechtel S A, Klepser M E.
Safety of aerosolized amphotericin B.
Expert Opin Drug Saf.
2007;
6
523-532
- 32
Sexauer W P, Fiel S B.
Aerosolized antibiotics in cystic fibrosis.
Semin Respir Crit Care Med.
2003;
24
717-726
- 33 Wilson R, Welte T, Polverinoet E et al.. Randomized, placebo-controlled, double-blind,
multi-center study to evaluate the safety and efficacy of ciprofloxacin dry powder
for inhalation (ciprofloxacin DPI) compared with placebo in patients with non-cystic
fibrosis bronchiectasis. American Thoracic Society (ATS), annual meeting May 13 – 18,
2011 Denver, USA; Abstract No. 22 734
Dr. Jessica Rademacher
Transplant-Ambulanz
Med. Hochschule Hannover
Carl-Neuberg-Str. 1
30625 Hannover
eMail: rademacher.jessica@mh-hannover.de
